Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2301studies shown
Showing 73-84 of 2,301
Device study icon
Not Yet RecruitingNCT07329153

Neuronavigated aiTBS for TRD

This study is looking at whether aiTBS can help people with Treatment Resistant Depression. Participants take part in aiTBS and complete follow-up assessments.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 65 Years
Countries
United States
Sponsor
University of Texas Southwestern Medical Center
Condition
Depression
Behavioral study icon
RecruitingNCT06005194

InMotion - Telehealth Delivered Exercise Promotion to Treat Major Depression After TBI

This study is comparing InMotion with Wait List Control (WLC) Condition for people with depression. Participants receive InMotion or Wait List Control (WLC) Condition and complete study visits and assessments.

Remote / online
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 18 Years to 64 Years
Countries
United States
Sponsor
University of Washington
Condition
Depression
Behavioral study icon
RecruitingNCT06938841

Maintenance rTMS for Depression (Maitr-De)

This study is looking at whether Transcranial Magnetic Stimulation (TMS) - Standard maintenance rTMS can help people with depression or Treatment Resistant Depression. Participants take part in Transcranial Magnetic Stimulation (TMS) - Standard maintenance rTMS and complete follow-up assessments.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 18 Years to 80 Years
Countries
United States, Australia
Sponsor
University of California, San Diego
Condition
Depression
Drug study icon
RecruitingNCT06559306

Treatment With Seltorexant for depression

This study is recruiting in the United States, in Argentina, in Brazil, .... It is testing treatment With Seltorexant for depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugA study involving a medication or substance.From 18 Years to 74 Years
Countries
United States, Argentina, Brazil, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Other study type icon
RecruitingNCT06080646

Reward Processing and Depressive Subtypes: Identifying Neural Biotypes

This observational study is following people with major depression Depressive Episode, Depressive Symptoms, or Anhedonia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionOtherFrom 18 Years to 70 Years
Countries
United States
Sponsor
San Francisco Veterans Affairs Medical Center
Condition
Depression
Drug study icon
RecruitingNCT06070766

RIVER At Home Ketamine Protocols

This observational study is following people with depression or anxiety to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

Remote / online
Why is this study shown?

This study is directly about Depression.

Depression, PTSD, ...DrugOver 18 Years
Countries
United States
Sponsor
RIVER Foundation
Condition
Depression, PTSD, ...
Other study type icon
RecruitingNCT07166289

Ultrasound Neuromodulation of Circuits and Negative Valence Systems in Treatment-Resistant Depression

This study is looking at care and outcomes for people with Treatment-Resistant Depression. Some participants may receive Sham LIFU instead of the study treatment, and direct benefit is not guaranteed.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Laureate Institute for Brain Research, Inc.
Condition
Depression
Drug study icon
Not Yet RecruitingNCT07685964

Pregnenolone for Addiction and Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Why is this study shown?

This study is directly about Depression.

Depression, AddictionDrugFrom 18 Years to 50 Years
Countries
United States
Sponsor
University of Texas Southwestern Medical Center
Condition
Depression, Addiction
Device study icon
Enrolling By InvitationNCT07369180

NQ Square TMS for MDD 1Dx3S Adults Multi-site Sham-controlled Protocol

This study is comparing Active Accelerated rTMS Treatment with Sham Accelerated Protocol for people with depression. Participants receive Active Accelerated rTMS Treatment or Sham Accelerated Protocol and complete study visits and assessments.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDeviceFrom 22 Years to 85 Years
Countries
United States
Sponsor
NeuroQore Inc.
Condition
Depression
Behavioral study icon
Enrolling By InvitationNCT06572683

Resonant Frequency rTMS: A Novel Approach to Target Circuit Modulation in Major Depressive Disorder

5 years for people with Mdd or Depression. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 21 Years to 75 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Depression
Drug study icon
RecruitingNCT06524830

VLS-01 Buccal Film, Compared to Placebo for treatment-resistant depression

This study is recruiting in the United States, in Australia, in Canada, .... It is testing VLS-01 Buccal Film, Compared to Placebo for treatment-resistant depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 65 Years
Countries
United States, Australia, Canada, ...
Sponsor
atai Therapeutics, Inc.
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.